Literature DB >> 20680256

The tubular epithelium in the initiation and course of intratubular nephrocalcinosis.

Benjamin A Vervaet1, Anja Verhulst, Marc E De Broe, Patrick C D'Haese.   

Abstract

Intratubular nephrocalcinosis is defined as the histological observation of calcium oxalate and/or calcium phosphate deposits retained within the lumen of the renal tubules. As the tubular epithelium is the primary interaction partner of crystals formed in the tubular fluid, the role of the epithelial cells in nephrocalcinosis has been investigated intensively. This review summarizes our current understanding on how the tubular epithelium mechanistically appears to be involved both in the initiation and in the course of nephrocalcinosis, with emphasis on in vivo observations.

Entities:  

Mesh:

Year:  2010        PMID: 20680256     DOI: 10.1007/s00240-010-0290-5

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  100 in total

1.  Calcium oxalate nephrolithiasis, a free or fixed particle disease.

Authors:  D J Kok; S R Khan
Journal:  Kidney Int       Date:  1994-09       Impact factor: 10.612

2.  Role of macrophages in nephrolithiasis in rats: an analysis of the renal interstitium.

Authors:  R de Water; C Noordermeer; A B Houtsmuller; A L Nigg; T Stijnen; F H Schröder; D J Kok
Journal:  Am J Kidney Dis       Date:  2000-09       Impact factor: 8.860

3.  Resolution of medullary nephrocalcinosis in children with metabolic bone disorders.

Authors:  Ari Auron; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2005-06-23       Impact factor: 3.714

4.  Incidence, ultrasonic patterns and resolution of nephrocalcinosis in very low birthweight infants.

Authors:  T Saarela; A Vaarala; P Lanning; M Koivisto
Journal:  Acta Paediatr       Date:  1999-06       Impact factor: 2.299

5.  Annexin II is present on renal epithelial cells and binds calcium oxalate monohydrate crystals.

Authors:  Vivek Kumar; Gerard Farell; Sergio Deganello; John C Lieske
Journal:  J Am Soc Nephrol       Date:  2003-02       Impact factor: 10.121

6.  The natural history of chronic allograft nephropathy.

Authors:  Brian J Nankivell; Richard J Borrows; Caroline L-S Fung; Philip J O'Connell; Richard D M Allen; Jeremy R Chapman
Journal:  N Engl J Med       Date:  2003-12-11       Impact factor: 91.245

7.  An active renal crystal clearance mechanism in rat and man.

Authors:  Benjamin A Vervaet; Anja Verhulst; Simonne E Dauwe; Marc E De Broe; Patrick C D'Haese
Journal:  Kidney Int       Date:  2008-09-10       Impact factor: 10.612

8.  Crystalluric and tubular epithelial parameters during the onset of intratubular nephrocalcinosis: illustration of the 'fixed particle' theory in vivo.

Authors:  Benjamin A Vervaet; Patrick C D'Haese; Marc E De Broe; Anja Verhulst
Journal:  Nephrol Dial Transplant       Date:  2009-08-29       Impact factor: 5.992

9.  Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones.

Authors:  Andrew E Evan; James E Lingeman; Fredric L Coe; Nicole L Miller; Sharon B Bledsoe; Andre J Sommer; James C Williams; Youzhi Shao; Elaine M Worcester
Journal:  Kidney Int       Date:  2008-04-30       Impact factor: 10.612

Review 10.  Physiopathology and etiology of stone formation in the kidney and the urinary tract.

Authors:  Andrew P Evan
Journal:  Pediatr Nephrol       Date:  2009-02-07       Impact factor: 3.714

View more
  10 in total

Review 1.  A hypothesis of calcium stone formation: an interpretation of stone research during the past decades.

Authors:  Hans-Göran Tiselius
Journal:  Urol Res       Date:  2011-01-19

2.  Simulating calcium salt precipitation in the nephron using chemical speciation.

Authors:  Allen L Rodgers; Shameez Allie-Hamdulay; Graham Jackson; Hans-Göran Tiselius
Journal:  Urol Res       Date:  2011-01-20

3.  Colony-stimulating factor-1 signaling suppresses renal crystal formation.

Authors:  Kazumi Taguchi; Atsushi Okada; Hiroshi Kitamura; Takahiro Yasui; Taku Naiki; Shuzo Hamamoto; Ryosuke Ando; Kentaro Mizuno; Noriyasu Kawai; Keiichi Tozawa; Kenichi Asano; Masato Tanaka; Ichiro Miyoshi; Kenjiro Kohri
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

4.  Meeting report of the "Symposium on kidney stones and mineral metabolism: calcium kidney stones in 2017".

Authors:  Agnieszka Pozdzik; Naim Maalouf; Emmanuel Letavernier; Isabelle Brocheriou; Jean-Jacques Body; Benjamin Vervaet; Carl Van Haute; Johanna Noels; Romy Gadisseur; Vincent Castiglione; Frédéric Cotton; Giovanni Gambaro; Michel Daudon; Khashayar Sakhaee
Journal:  J Nephrol       Date:  2019-01-24       Impact factor: 3.902

5.  Aluminum citrate prevents renal injury from calcium oxalate crystal deposition.

Authors:  Lauren M Besenhofer; Marie C Cain; Cody Dunning; Kenneth E McMartin
Journal:  J Am Soc Nephrol       Date:  2012-11-08       Impact factor: 10.121

Review 6.  Human kidney stones: a natural record of universal biomineralization.

Authors:  Mayandi Sivaguru; Jessica J Saw; Elena M Wilson; John C Lieske; Amy E Krambeck; James C Williams; Michael F Romero; Kyle W Fouke; Matthew W Curtis; Jamie L Kear-Scott; Nicholas Chia; Bruce W Fouke
Journal:  Nat Rev Urol       Date:  2021-05-24       Impact factor: 14.432

7.  A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.

Authors:  Dawn Milliner; Bernd Hoppe; Jaap Groothoff
Journal:  Urolithiasis       Date:  2017-07-17       Impact factor: 3.436

8.  Metabolomic analysis reveals a protective effect of Fu-Fang-Jin-Qian-Chao herbal granules on oxalate-induced kidney injury.

Authors:  Wei Chen; Wen-Rui Liu; Jie-Bin Hou; Jia-Rong Ding; Zhong-Jiang Peng; Song-Yan Gao; Xin Dong; Jun-Hua Ma; Qi-Shan Lin; Jian-Rao Lu; Zhi-Yong Guo
Journal:  Biosci Rep       Date:  2019-02-22       Impact factor: 3.840

Review 9.  Improving Treatment Options for Primary Hyperoxaluria.

Authors:  Bernd Hoppe; Cristina Martin-Higueras
Journal:  Drugs       Date:  2022-07-02       Impact factor: 11.431

10.  Lanthanum carbonate to control plasma and urinary oxalate level in type 1 primary hyperoxaluria?

Authors:  Agnieszka Pozdzik; Cristina David; Jelle Vekeman; Frederik Tielens; Michel Daudon
Journal:  IJU Case Rep       Date:  2021-05-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.